In CTR-1011, injection-site issues happened in 50.7% of tesamorelin users versus 21.4% on placebo
While GLP-1 therapies to date have conventionally been injectables, oral formulations are beginning to make their mark on the back of convenience and, therefore, better patient compliance
Here's what we'll cover Here's what we'll cover Here's what we'll cover Key takeaways Optimizing eating habits while taking a GLP-1 medication helps support the medication's effects, whether the goal is weight loss, blood sugar management, or both
Research other insurance plans: Open enrollment periods (OEP) are typically from Nov
Saxenda is a prescription weight-management medicine containing liraglutide 6 mg/ml, a GLP-1 (glucagon-like peptide-1) receptor agonist
Properly disposing of the used needle/pen in a sharps container